Prediction of <sup>177</sup>Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on <sup>68</sup>Ga-DOTATATE PET/CT.

Lee, Hwan; Kipnis, Sarit T; Niman, Remy; O'Brien, Sophia R; Eads, Jennifer R; Katona, Bryson W; Pryma, Daniel A

Prediction of ¹⁷⁷Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on ⁶⁸Ga-DOTATATE PET/CT.

Lee, Hwan; Kipnis, Sarit T; Niman, Remy; O'Brien, Sophia R; Eads, Jennifer R; Katona, Bryson W; Pryma, Daniel A.

Afiliação

Lee H; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Kipnis ST; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Niman R; Department of Medicine, Georgetown University, Washington, DC 20007, USA.
O'Brien SR; MIM Software Inc., Cleveland, OH 44122, USA.
Eads JR; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Katona BW; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Pryma DA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.

Cancers (Basel) ; 16(1)2023 Dec 31.

Article em En | MEDLINE | ID: mdl-38201627

Palavras-chave

177Lu-DOTATATE; 68Ga-DOTATATE; neuroendocrine tumor; positron emission tomography computed tomography; prognostic factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google